Dr. Reddy’s infuses Rs. 565 crore in its Russian subsidiary
The company has made an investment of Rs. 565.40 crore in DRL Russia for a total equity stake of 45.19%
The company has made an investment of Rs. 565.40 crore in DRL Russia for a total equity stake of 45.19%
The wholly owned subsidiary will carry on the business of all types of research and development and other related services
QuantumNexis will serve as the innovative engine for HCTI's recurring revenue business lines
This strategic expansion marks a significant step in the company's global growth strategy
The Subsidiary has received one inspectional observation in Form 483
This registration authorizes Nureca Technologies to continue manufacturing and exporting asuite of medical devices to the United States
The newly setup entity, Emcutix Biopharmaceuticals Limited, plans to significantly expand Emcure’s offerings
he company will focus on production of any pharmaceutical and biotechnological products
Ace Lab conducts 170 batches of testing per month and has capacity to do more than 250 batches per month
Subscribe To Our Newsletter & Stay Updated